Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Janowski, Miroslaw ^a,b,c   Walczak, Piotr ^b,c,d   Kropiwnicki, Tomasz ^e   Jurkiewicz, Elzbieta ^e   Domanska Janik, Krystyna ^a   Bulte, Jeff W M ^b,c,f   Lukomska, Barbara ^a   Roszkowski, Marcin ^e  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^e CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^f Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; MAGNETITE NANOPARTICLE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL SEPARATION; CELL TRACKING; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEASIBILITY STUDY; GLOBAL CEREBRAL ISCHEMIA; HUMAN; HUMAN CELL; IN VITRO STUDY; LATERAL BRAIN VENTRICLE; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; STEM CELL; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD; BIOLOGICAL THERAPY; CHEMISTRY; CYTOLOGY; INFANT; PROCEDURES;

BRAIN ISCHEMIA; CELL TRACKING; CELL- AND TISSUE-BASED THERAPY; CONTRAST MEDIA; HUMANS; INFANT; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84903380463     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097631     Document Type: Article

References (37)

1. Lin TC, Lee OK (2008) Stem cells: a primer. Chin J Physiol 51: 197-207.
2. Placzek MR, Chung IM, Macedo HM, Ismail S, Mortera Blanco T, et al. (2009) Stem cell bioprocessing: fundamentals and principles. J R Soc Interface 6: 209-232.
3. Farin A, Liu CY, Elder JB, Langmoen IA, Apuzzo ML (2009) The biological restoration of central nervous system architecture and function: part 1- foundations and historical landmarks in contemporary stem cell biology. Neurosurgery 64: 15-39; discussion 34.
4. Hess DC, Borlongan CV (2008) Stem cells and neurological diseases. Cell Prolif 41 Suppl 1: 94-114. (Pubitemid 350295855)
5. Lindvall O, Rehncrona S, Gustavii B, Brundin P, Astedt B, et al. (1988) Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet 2: 1483-1484. (Pubitemid 19016664)
6. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, et al. (1992) Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 327: 1556-1563.
7. Mackay-Sim A, Feron F, Cochrane J, Bassingthwaighte L, Bayliss C, et al. (2008) Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3- year clinical trial. Brain 131: 2376-2386.
8. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, et al. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54: 403-414. (Pubitemid 37072046)
9. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344: 710-719. (Pubitemid 32204988)
10. Janowski M, Walczak P, Date I (2010) Intravenous route of cell delivery for treatment of neurological disorders: a meta-analysis of preclinical results. Stem Cells Dev 19: 5-16.
11. Battistella V, de Freitas GR, da Fonseca LM, Mercante D, Gutfilen B, et al. (2011) Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med 6: 45-52.
12. Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr, et al. (2011) Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol 70: 59-69.
13. Bulte JW (2009) In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol 193: 314-325.
14. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, et al. (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nature biotechnology 23: 1407-1413. (Pubitemid 41679393)
15. Zhu J, Zhou L, XingWu F (2006) Tracking neural stem cells in patients with brain trauma. N Engl J Med 355: 2376-2378. (Pubitemid 44837805)
16. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, et al. (2010) Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67: 1187-1194.
17. Toso C, Vallee JP, Morel P, Ris F, Demuylder-Mischler S, et al. (2008) Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 8: 701-706. (Pubitemid 351287550)
18. Richards JM, Shaw CA, Lang NN, Williams MC, Semple SI, et al. (2012) In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. Circ Cardiovasc Imaging 5: 509-517.
19. Jozwiak S, Habich A, Kotulska K, Sarnowska A, Kropiwnicki T, et al. (2010) Intracerebrobentricular Transplantation of Cord Blood-Derived Neural Progenitors in a Child with Severe Global Brain Ischemic Injury. Cell Medicine 1: 71-80.
20. Janowski M, Kuzma-Kozakiewicz M, Binder D, Habisch HJ, Habich A, et al. (2008) Neurotransplantation in mice: the concorde-like position ensures minimal cell leakage and widespread distribution of cells transplanted into the cisterna magna. Neurosci Lett 430: 169-174.
21. Bates D (2005) The vegetative state and the Royal College of Physicians guidance. Neuropsychol Rehabil 15: 175-183.
22. Habich A, Jurga M, Markiewicz I, Lukomska B, Bany-Laszewicz U, et al. (2006) Early appearance of stem/progenitor cells with neural-like characteristics in human cord blood mononuclear fraction cultured in vitro. Exp Hematol 34: 914-925.
23. Buzanska L, Jurga M, Stachowiak EK, Stachowiak MK, Domanska-Janik K (2006) Neural stem-like cell line derived from a nonhematopoietic population of human umbilical cord blood. Stem Cells Dev 15: 391-406. (Pubitemid 44100016)
24. Bulte JW, Arbab AS, Douglas T, Frank JA (2004) Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol 386: 275-299. (Pubitemid 38657598)
25. Gorelik M, Janowski M, Galpoththawela C, Rifkin R, Levy M, et al. (2012) Non- Invasive Monitoring of Immunosuppressive Drug Efficacy to Prevent Rejection of Intracerebral Glial Precursor Allografts. Cell Transplant in press.
26. Janowski M, Date I (2009) Systemic neurotransplantation-a problem-oriented systematic review. Rev Neurosci 20: 39-60.
27. Geffner LF, Santacruz P, Izurieta M, Flor L, Maldonado B, et al. (2008) Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 17: 1277-1293.
28. Huang H, Chen L, Xi H, Wang H, Zhang J, et al. (2008) Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clin Transplant 22: 710-718.
29. Huang H, Chen L, Xi H, Wang Q, Zhang J, et al. (2009) [Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 23: 14-20.
30. Deda H, Inci MC, Kurekci AE, Sav A, Kayihan K, et al. (2009) Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 11: 18- 25.
31. Saberi H, Moshayedi P, Aghayan HR, Arjmand B, Hosseini SK, et al. (2008) Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett 443: 46-50.
32. Tupitsyn NN, Yaryghin VN, Bryukhovetskiy AS, Grivtsova LY, Mentkevich GL, et al. (2006) Immunophenotypic peculiarities of mobilized stem (CD34+)cells in blood from patients with severe spinal cord injury. J Biol Regul Homeost Agents 20: 36-40.
33. Ashwal S, Obenaus A, Snyder EY (2009) Neuroimaging as a basis for rational stem cell therapy. Pediatr Neurol 40: 227-236.
34. Walczak P, Kedziorek DA, Gilad AA, Barnett BP, Bulte JW (2007) Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn Reson Med 58: 261-269. (Pubitemid 47267643)
35. Weller RO (2005) Microscopic morphology and histology of the human meninges. Morphologie 89: 22-34.
36. Berman SC, Galpoththawela C, Gilad AA, Bulte JW, Walczak P (2011) Longterm MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med 65: 564-574.
37. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, et al. (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23: 1407-1413. (Pubitemid 41679393)